← FDA Drug Approvals (Drugs@FDA)

LIDOCAINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2026-03-20

Drug application

FDA Application #

ANDA218676

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIDOCAINE HYDROCHLORIDE

Generic name

Lidocaine Hydrochloride

Active ingredients

LIDOCAINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

QUAGEN

First approval

2026-03-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown